PharmaDirections Succeeds Through its Client’s Successes: Cortendo…
Cortendo AB with support from their preclinical development partner, PharmaDirections, Inc. received a positive opinion from the European Medicines Agency for NormoCort.
(PRWeb June 26, 2012)
Read the full story at http://www.prweb.com/releases/2012/6/prweb9539917.htmClick here for reuse options!
Copyright 2012 Biotechblog
Comments are closed.